Previous 10 | Next 10 |
Shares of Aytu BioPharma Inc. (NASDAQ:AYTU) traded at a new 52-week low today of $4.23. This new low was reached on approximately average trading volume as 1.1 million shares traded hands, while the average 30-day volume is approximately 1.5 million shares. Aytu BioPharma Inc is a specia...
Aytu BioPharma Inc. (NASDAQ:AYTU) traded today at a new 52-week low of $4.29. So far today approximately 1.1 million shares have been exchanged, as compared to an average 30-day volume of 1.5 million shares. Aytu BioPharma Inc. share prices have moved between a 52-week high of $15.50 and...
Shares of Aytu BioPharma Inc. (NASDAQ:AYTU) traded today at $4.44, breaking its 52-week low. So far today approximately 1.1 million shares have been exchanged, as compared to an average 30-day volume of 1.6 million shares. Aytu BioPharma Inc. (NASDAQ:AYTU) has potential upside of 280.6% ...
Shares of Aytu BioPharma Inc. (NASDAQ:AYTU) traded at a new 52-week low today of $4.61. Approximately 1.1 million shares have changed hands today, as compared to an average 30-day volume of 1.5 million shares. Aytu BioPharma Inc is a specialty pharmaceutical company commercializing novel...
Aytu BioPharma (AYTU) perks up 3.5% premarket after announcing data from the first in-human trial studying the safety and effectiveness of ultraviolet A ((UVA)) light endotracheal catheter in critically ill COVID-19 patientsThe study concluded that endotracheal UVA light treatment w...
Results Indicate That Endotracheal UVA Light Catheter Therapy is Associated with Significant Reduction in SARS-CoV-2 Viral Load and Improvement in Clinical Outcomes in Mechanically Ventilated COVID-19 Patients ENGLEWOOD, CO / ACCESSWIRE / June 28, 2021 / Aytu BioPharma, Inc. (NASDAQ:AYT...
Why These Penny Stocks Are Gaining so Much Attention It’s not uncommon to see penny stocks push up in value after big news is announced. This could be news related to the company specifically, or the industry that it operates in. Because penny stocks are so speculative, news ...
sitox/E+ via Getty Images Aytu (AYTU) Biopharma is the top performing biotech stock in afternoon trading and is currently up 21%. The surge is happening despite any news from the company or catalysts that might impact the share price. Aytu's lead candidate is AR101 (enzastaurin) for vasc...
Gainers: Virpax Pharmaceuticals (VRPX) +16%, Anavex Life Sciences AVXL +15%, MediciNova MNOV +14%, Aytu Biopharma (AYTU) +14%, Applied Molecular Transport (AMTI) +8%.Losers: Aptevo Therapeutics (APVO) -18%, Intec Pharma (NTEC) -16%, Conformis ...
MediciNova (MNOV) +52% on positive MN-166 data.Raven Industries (RAVN) +50% on being acquired by CNHI for $58.0 per share.Torchlight Energy Resources (TRCH) +39% after update on proposed business combination timing and date for preferred dividend.Hennessy Capital Investment Cor...
News, Short Squeeze, Breakout and More Instantly...
Company receives proceeds of $3.5 million through exercise of warrants, a portion of which was used to pay down debt Interest rate on new $13.0 million term loan reduced by approximately 350 basis points today, potentially saving the Company $1.3 million over the life of the term loan T...
Phoenix, Arizona and New York, New York--(Newsfile Corp. - May 29, 2024) - Lytham Partners, a leading investor relations and corporate access firm, today announced the schedule for its Spring 2024 Investor Conference taking place virtually on May 30, 2024. More than 40 companies will be available...
DENVER, CO / ACCESSWIRE / May 23, 2024 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced that Josh Disbrow, CEO, will participate in a webcasted fireside chat and host one-on-one meetings with inv...